Proactive Investors - Run By Investors For Investors

Porta Communications appoints new joint chief executives

Steffan Williams, the previous group chief executive, has left with immediate effect
Australia
100 staff now in Australia

Marketing and PR group Porta Communications PLC (LON:PTCM) has appointed Emma Kane and Brian Tyson as it new joint chief executives.

Emma Kane is currently chief executive of Redleaf Communications, which will be combined with the UK arm of Newgate.

Brian Tyson is managing partner of Newgate Australia and will continue to run that business while Kane and Tyson will together manage the international network as joint CEOs.

READ: Porta Communications enjoyed strong second half of 2017

Steffan Williams, the previous group chief executive, has left with immediate effect.

John Foley, chairman, said: "Redleaf has been a great acquisition for Porta and it now makes absolute strategic sense to combine the business with Newgate and create an enlarged business to capitalise on the expertise and proven track records of the exceptional people at both firms.

 "In Australia, from start-up five years ago with a core group of 8 people in offices in Sydney and Melbourne, the business now has more than 100 professional staff and opened additional offices in Canberra, Brisbane and Perth.

 "Together, Brian and Emma will give us the leadership we need on both sides of the world to help roll out an integrated offering in our major markets.”

View full PTCM profile View Profile

Porta Communications PLC Timeline

Related Articles

clapperboard
November 16 2018
According to Liberum, FFI expects the US performance to normalise by the end of this financial year
Throne of Glass
October 23 2018
Rowling, Rowling, Rowling ... keep those titles rolling. Mind you, it's not all about Ms Rowling; Sarah J Maas title revenues grew 47% in the first half of the financial year and dieters are gorging on Tom Kerridge's books
ipad
September 19 2018
“Cello Health is successfully building its early stage asset development advisory platform for biotech clients, as well as growing its core later stage and post-launch franchise with pharmaceutical clients”

© Proactive Investors 2018

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use